BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20657114)

  • 21. Adult stem cell treatment of scleroderma.
    Tyndall A; Furst DE
    Curr Opin Rheumatol; 2007 Nov; 19(6):604-10. PubMed ID: 17917542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caring for the Patient With Limited Systemic Scleroderma.
    Lachner KD
    Orthop Nurs; 2016; 35(1):5-10; quiz 11-2. PubMed ID: 26814000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autologous stem cell transplantation for systemic sclerosis.
    Farge D; Nash R; Laar JM
    Autoimmunity; 2008 Dec; 41(8):616-24. PubMed ID: 18958754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis.
    Badea I; Taylor M; Rosenberg A; Foldvari M
    Rheumatology (Oxford); 2009 Mar; 48(3):213-21. PubMed ID: 19022832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Esophageal motor abnormalities in children and adolescents with scleroderma and mixed connective tissue disease.
    Flick JA; Boyle JT; Tuchman DN; Athreya BH; Doughty RA
    Pediatrics; 1988 Jul; 82(1):107-11. PubMed ID: 3288952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Systemic sclerosis. Which therapies?].
    Bettoni L
    Minerva Med; 2001 Apr; 92(2):121-7. PubMed ID: 11323574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phototherapy: a promising treatment option for skin sclerosis in scleroderma?
    Sunderkötter C; Kuhn A; Hunzelmann N; Beissert S
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii52-iii54. PubMed ID: 16987838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nursing problems of patients with systemic sclerosis.
    Sierakowska M; Sierakowski S; Lewko J; Jankowiak B; Kowalczuk K; Krajewska-Kułak E
    Adv Med Sci; 2007; 52 Suppl 1():147-52. PubMed ID: 18232102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
    Perera A; Fertig N; Lucas M; Rodriguez-Reyna TS; Hu P; Steen VD; Medsger TA
    Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Childhood systemic sclerosis.
    Zulian F; Martini G
    Curr Opin Rheumatol; 2007 Nov; 19(6):592-7. PubMed ID: 17917540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database.
    Martini G; Foeldvari I; Russo R; Cuttica R; Eberhard A; Ravelli A; Lehman TJ; de Oliveira SK; Susic G; Lyskina G; Nemcova D; Sundel R; Falcini F; Girschick H; Lotito AP; Buoncompagni A; Sztajnbok F; Al-Mayouf SM; Orbàn I; Ferri C; Athreya BH; Woo P; Zulian F;
    Arthritis Rheum; 2006 Dec; 54(12):3971-8. PubMed ID: 17133611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scleroderma--clinical and pathological advances.
    Denton CP; Black CM
    Best Pract Res Clin Rheumatol; 2004 Jun; 18(3):271-90. PubMed ID: 15158741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus.
    Khorshid O; Hosing C; Bibawi S; Ueno N; Reveille J; Mayes MD; Champlin RE
    J Rheumatol; 2004 Dec; 31(12):2513-6. PubMed ID: 15570660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic and localized scleroderma.
    Chung L; Lin J; Furst DE; Fiorentino D
    Clin Dermatol; 2006; 24(5):374-92. PubMed ID: 16966019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: concerns over the use of total-body irradiation in systemic sclerosis.
    Burt RK; Patel D; Thomas J; Yeager A; Traynor A; Heipe F; Arnold R; Marmont A; Collier D; Glatstein E; Snowden J
    Bone Marrow Transplant; 2004 Nov; 34(9):745-51. PubMed ID: 15361910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Red flags in scleroderma.
    Li Q; Sahhar J; Littlejohn G
    Aust Fam Physician; 2008 Oct; 37(10):831-4. PubMed ID: 19002303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current options for the treatment of systemic scleroderma.
    McGee BA; Barnett MD; Small RE
    Clin Pharm; 1991 Jan; 10(1):14-25. PubMed ID: 1999084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic sclerosis (scleroderma). Clinical management of its major complications.
    Legerton CW; Smith EA; Silver RM
    Rheum Dis Clin North Am; 1995 Feb; 21(1):203-16. PubMed ID: 7732169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Systemic sclerosis. A diagnostic and follow-up program].
    Rødevand E; Skomsvoll JF; Ostensen M
    Tidsskr Nor Laegeforen; 1997 Sep; 117(22):3221-3. PubMed ID: 9411861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of systemic sclerosis.
    Medsger TA
    Rheum Dis Clin North Am; 1989 Aug; 15(3):513-31. PubMed ID: 2672135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.